Integra Therapeutics
Signal active
Organization
Contact Information
Overview
Integra Therapeutics is a developer of next-generation of gene editing tools to cure diseases.
About
Industries
Biotechnology, Health Care, Genetics
Founded
2020
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Integra Therapeutics headquartered in Europe, operates in the Biotechnology, Health Care, Genetics sector. The company focuses on Biotechnology and has secured $873.7M in funding across 48 round(s). With a team of 1-10 employees, Integra Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Integra Therapeutics, raised $8.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$18.2M
Details
3
Integra Therapeutics has raised a total of $18.2M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 5.1M | ||
| 2022 | Seed | 1.7M | ||
| 2024 | Early Stage Venture | 8.7M |
Investors
Integra Therapeutics is funded by 14 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Integra Therapeutics | - | FUNDING ROUND - Integra Therapeutics | 2.7M |
| EIC Accelerator | - | FUNDING ROUND - EIC Accelerator | 2.7M |
| Integra Therapeutics | - | FUNDING ROUND - Integra Therapeutics | 8.7M |
| EIC Accelerator | - | FUNDING ROUND - EIC Accelerator | 8.7M |
Recent Activity
There is no recent news or activity for this profile.